Editorial: evidence is growing for protective effects of 5-aminosalicylates against colitis-associated cancer-authors' reply

S Bonovas¹, G Fiorino¹, T Lytras^{2

3

4}, G Nikolopoulos⁵, L Peyrin-Biroulet⁶, S Danese^{1

7}

Affiliations

¹ Department of Gastroenterology, IBD Center, Humanitas Clinical and Research Center, Milan, Italy.
² Hellenic Center for Disease Control and Prevention, Athens, Greece.
³ Department of Experimental and Health Sciences, Pompeu Fabra University, Barcelona, Spain.
⁴ Barcelona Institute for Global Health, Barcelona, Spain.
⁵ Medical School, University of Cyprus, Nicosia, Cyprus.
⁶ Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, University of Lorraine, Vandoeuvre-lès-Nancy, France.
⁷ Department of Biomedical Sciences, Humanitas University, Milan, Italy.

Editorial

S Bonovas et al. Aliment Pharmacol Ther. 2017 Jun.

. 2017 Jun;45(12):1554-1555.

doi: 10.1111/apt.14084.

S Bonovas¹, G Fiorino¹, T Lytras^{2

3

4}, G Nikolopoulos⁵, L Peyrin-Biroulet⁶, S Danese^{1

7}

¹ Department of Gastroenterology, IBD Center, Humanitas Clinical and Research Center, Milan, Italy.
² Hellenic Center for Disease Control and Prevention, Athens, Greece.
³ Department of Experimental and Health Sciences, Pompeu Fabra University, Barcelona, Spain.
⁴ Barcelona Institute for Global Health, Barcelona, Spain.
⁵ Medical School, University of Cyprus, Nicosia, Cyprus.
⁶ Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, University of Lorraine, Vandoeuvre-lès-Nancy, France.
⁷ Department of Biomedical Sciences, Humanitas University, Milan, Italy.

No abstract available

Comment on

Systematic review with meta-analysis: use of 5-aminosalicylates and risk of colorectal neoplasia in patients with inflammatory bowel disease.
Bonovas S, Fiorino G, Lytras T, Nikolopoulos G, Peyrin-Biroulet L, Danese S. Bonovas S, et al. Aliment Pharmacol Ther. 2017 May;45(9):1179-1192. doi: 10.1111/apt.14023. Epub 2017 Mar 6. Aliment Pharmacol Ther. 2017. PMID: 28261835
Editorial: evidence is growing for protective effects of 5-aminosalicylates against colitis-associated cancer.
Collins PD. Collins PD. Aliment Pharmacol Ther. 2017 Jun;45(12):1553-1554. doi: 10.1111/apt.14072. Aliment Pharmacol Ther. 2017. PMID: 28503866 No abstract available.